181 related articles for article (PubMed ID: 21125314)
1. Treatment of cultured human astrocytes and vascular endothelial cells with protein kinase CK2 inhibitors induces early changes in cell shape and cytoskeleton.
Kramerov AA; Golub AG; Bdzhola VG; Yarmoluk SM; Ahmed K; Bretner M; Ljubimov AV
Mol Cell Biochem; 2011 Mar; 349(1-2):125-37. PubMed ID: 21125314
[TBL] [Abstract][Full Text] [Related]
2. Cell rounding in cultured human astrocytes and vascular endothelial cells upon inhibition of CK2 is mediated by actomyosin cytoskeleton alterations.
Kramerov AA; Ahmed K; Ljubimov AV
J Cell Biochem; 2012 Sep; 113(9):2948-56. PubMed ID: 22552886
[TBL] [Abstract][Full Text] [Related]
3. Raf-1/CK2 and RhoA/ROCK signaling promote TNF-α-mediated endothelial apoptosis via regulating vimentin cytoskeleton.
Yang L; Tang L; Dai F; Meng G; Yin R; Xu X; Yao W
Toxicology; 2017 Aug; 389():74-84. PubMed ID: 28743511
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites.
Kramerov AA; Saghizadeh M; Caballero S; Shaw LC; Li Calzi S; Bretner M; Montenarh M; Pinna LA; Grant MB; Ljubimov AV
Mol Cell Biochem; 2008 Sep; 316(1-2):177-86. PubMed ID: 18612802
[TBL] [Abstract][Full Text] [Related]
5. Novel small molecule protein kinase CK2 inhibitors exert potent antitumor effects on T98G and SEGA cells in vitro.
Pucko E; Ostrowski R; Matyja E
Folia Neuropathol; 2019; 57(3):239-248. PubMed ID: 31588710
[TBL] [Abstract][Full Text] [Related]
6. DMAT, an inhibitor of protein kinase CK2 induces reactive oxygen species and DNA double strand breaks.
Schneider CC; Hessenauer A; Götz C; Montenarh M
Oncol Rep; 2009 Jun; 21(6):1593-7. PubMed ID: 19424641
[TBL] [Abstract][Full Text] [Related]
7. The selectivity of inhibitors of protein kinase CK2: an update.
Pagano MA; Bain J; Kazimierczuk Z; Sarno S; Ruzzene M; Di Maira G; Elliott M; Orzeszko A; Cozza G; Meggio F; Pinna LA
Biochem J; 2008 Nov; 415(3):353-65. PubMed ID: 18588507
[TBL] [Abstract][Full Text] [Related]
8. Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina.
Kramerov AA; Saghizadeh M; Pan H; Kabosova A; Montenarh M; Ahmed K; Penn JS; Chan CK; Hinton DR; Grant MB; Ljubimov AV
Am J Pathol; 2006 May; 168(5):1722-36. PubMed ID: 16651637
[TBL] [Abstract][Full Text] [Related]
9. Selectivity analysis of protein kinase CK2 inhibitors DMAT, TBB and resorufin in cisplatin-induced stress responses.
Fritz G; Issinger OG; Olsen BB
Int J Oncol; 2009 Nov; 35(5):1151-7. PubMed ID: 19787270
[TBL] [Abstract][Full Text] [Related]
10. The Role of p38 and CK2 Protein Kinases in the Response of RAW 264.7 Macrophages to Lipopolysaccharide.
Glushkova OV; Parfenyuk SB; Novoselova TV; Khrenov MO; Lunin SM; Novoselova EG
Biochemistry (Mosc); 2018 Jun; 83(6):746-754. PubMed ID: 30195331
[TBL] [Abstract][Full Text] [Related]
11. An unbiased evaluation of CK2 inhibitors by chemoproteomics: characterization of inhibitor effects on CK2 and identification of novel inhibitor targets.
Duncan JS; Gyenis L; Lenehan J; Bretner M; Graves LM; Haystead TA; Litchfield DW
Mol Cell Proteomics; 2008 Jun; 7(6):1077-88. PubMed ID: 18258654
[TBL] [Abstract][Full Text] [Related]
12. TNFα inhibits IGFBP-3 through activation of p38α and casein kinase 2 in human retinal endothelial cells.
Zhang Q; Soderland D; Steinle JJ
PLoS One; 2014; 9(7):e103578. PubMed ID: 25073020
[TBL] [Abstract][Full Text] [Related]
13. Phosphoinositide 3-kinase induced activation and cytoskeletal translocation of protein kinase CK2 in protease activated receptor 1-stimulated platelets.
Nakanishi K; Toyoda H; Tanaka S; Yamamoto H; Komada Y; Gabazza EC; Hayashi T; Suzuki K; Ido M
Thromb Res; 2010 Dec; 126(6):511-6. PubMed ID: 21055793
[TBL] [Abstract][Full Text] [Related]
14. A specific inhibitor of protein kinase CK2 delays gamma-H2Ax foci removal and reduces clonogenic survival of irradiated mammalian cells.
Zwicker F; Ebert M; Huber PE; Debus J; Weber KJ
Radiat Oncol; 2011 Feb; 6():15. PubMed ID: 21310046
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of CK2 inhibitor (E)-3-(2,3,4,5-tetrabromophenyl)acrylic acid (TBCA) in regulation of platelet function.
Ryu SY; Kim S
Eur J Pharmacol; 2013 Nov; 720(1-3):391-400. PubMed ID: 24140231
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the epithelial Na+ channel by the protein kinase CK2.
Bachhuber T; Almaça J; Aldehni F; Mehta A; Amaral MD; Schreiber R; Kunzelmann K
J Biol Chem; 2008 May; 283(19):13225-32. PubMed ID: 18308722
[TBL] [Abstract][Full Text] [Related]
17. Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library.
Hung MS; Xu Z; Lin YC; Mao JH; Yang CT; Chang PJ; Jablons DM; You L
BMC Cancer; 2009 May; 9():135. PubMed ID: 19419583
[TBL] [Abstract][Full Text] [Related]
18. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
Cozza G; Mazzorana M; Papinutto E; Bain J; Elliott M; di Maira G; Gianoncelli A; Pagano MA; Sarno S; Ruzzene M; Battistutta R; Meggio F; Moro S; Zagotto G; Pinna LA
Biochem J; 2009 Jul; 421(3):387-95. PubMed ID: 19432557
[TBL] [Abstract][Full Text] [Related]
19. Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization.
Ljubimov AV; Caballero S; Aoki AM; Pinna LA; Grant MB; Castellon R
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4583-91. PubMed ID: 15557471
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase CK2 inhibition induces cell death via early impact on mitochondrial function.
Qaiser F; Trembley JH; Kren BT; Wu JJ; Naveed AK; Ahmed K
J Cell Biochem; 2014 Dec; 115(12):2103-15. PubMed ID: 25043911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
